Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Description

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

Conditions

Motion Sickness

Talk to us

Study Overview

On this page

Study Details

Study overview

An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel

Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Condition
Motion Sickness
Intervention / Treatment

-

Contacts and Locations

Santa Monica

Santa Monica Clinical Trials, Santa Monica, California, United States, 90404

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * History of Motion Sickness
  • * Age 18-75
  • * Nausea-inducing disorder other than motion sickness
  • * BMI \> 40
  • * History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists

Ages Eligible for Study

18 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Vanda Pharmaceuticals,

Study Record Dates

2025-04-30